Guide to Clinical Trials conducted under the CTR in Ireland
USFDA Electronic Submission of IND Safety Reports - Technical Conformance Guide
USFDA Guidance on Electronic PostMarketing Safety Reporting
Guidelines on Labeling Requirements of Drug Products under Maximum Retail Price - Philippines FDA
SFDA's Product Classification Guidance
Pakistan (DRAP) Draft Guidelines on FP Labeling & Packaging and BA-BE Guidelines
FDA's Considerations for Waiver Requests for pH Adjusters in Generic Drug Products
FDA's Bioavailability Guidance for NDAs or INDs- General consideration
FDA's MAPP on Complex Product Classification for Generic Development
HPRA Guide to Parallel Imports of Human Medicines - Ireland
FDA Guidance:Providing Submissions in Electronic & Non-Elec Format—Promotional Labeling &Advertising
EMA Draft Guidance- How To Approach the Protection Clinical Trial Information System (CTIS)
ICH-Draft Guideline on Pediatric Extrapolation & FInal Guidance on Considerations for Clinical Study
Voluntary GVP Inspection on Pharma Product Registration Holders- Malaysia’s NPRA
ICH's updated Draft Guidelines on Analytical Method Development
Guide on Microplastic Usage - IPEC Europe and IPEC-Americas "How to Document"
EMA Guidance on Post-Authorisation Procedural Advice for CAP users & EudraVigilance Reg. Manual
EMA Guidance on GVP for PPP & Parallel EMA/EUnetHTA 21 Consultation
Guidance on Renewal & Discontinuation of Authorisation on change of Status -Swiss Medic
UK MHRA: Guidance on "Advertise your Medicines"